Centrum Capital Q1 FY27: Board meet on Aug 12, 2026

Overview: key date set for Q1 FY27 results

Centrum Capital Limited has informed stock exchanges that its Board of Directors will meet on Wednesday, August 12, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. The intimation is a schedule update under the SEBI Listing Regulations and does not contain any financial numbers for the quarter. The results, both standalone and consolidated, are expected to be approved at the meeting. For investors, the filing matters because it pins down the decision date and triggers routine compliance steps around trading restrictions. Centrum Capital trades on BSE and NSE and is categorised under the NBFC segment.

Board meeting notice under Regulation 29

The company said it has given advance notice under Regulation 29 of the SEBI Listing Regulations. The stated purpose is to consider and approve the unaudited financial results, standalone and consolidated, for the quarter ended June 30, 2026. The company clarified that the intimation is only about scheduling. It also stated that the detailed notice will be available on the company website and on the stock exchange websites. The document was signed and submitted on June 25, 2026 by Balakrishna Kumar, Company Secretary and Compliance Officer (Membership No.: A51901). No operational updates or balance sheet commentary was included in the notice.

Trading window closure: July 1 to August 14

Alongside the board meeting schedule, Centrum Capital disclosed a trading-window closure for designated persons under its code of conduct on insider trading. The trading window is closed from Wednesday, July 1, 2026 to Friday, August 14, 2026, both days inclusive. The company stated that the closure is linked to the declaration of the unaudited financial results. It also said that all designated persons were informed of the closure as per the code. Such closures are standard for listed companies around results announcements, but the dates provide clarity on the compliance calendar.

Stock snapshot and identifiers cited in the material

The market data referenced shows Centrum Capital trading at around Rs 24, with a reported change of -0.98 (-3.92%). The day’s range cited is Rs 23.88 to Rs 24.98. The preview text also references a market capitalisation of Rs 1,191 crore and notes the price-to-earnings multiple as “not meaningful”, consistent with negative earnings. The scrip identifiers mentioned include BSE: 501150 and NSE: CENTRUMEQ, with ISIN code INE660C01027.

Q1 FY27 estimates published in the preview

A results preview included a range estimate for Q1 FY27 and a 12-month target band. The revenue estimate range is Rs 865 to Rs 995 crore, while the net profit or PAT estimate is a loss range of Rs -47 to Rs -60 crore. The preview also carries an indicative results window of July-August 2026 and a 12-month target range of Rs 21 to Rs 24 (Uniresearch estimate). The same material states Centrum Capital was trading at Rs 24, and describes the stance as “tracking with a cautious bias.”

What the estimate framework is based on

The preview states it applies a trailing-growth framework to the company’s Q1 FY26 base. It cites Q1 FY26 revenue of Rs 1,041 crore and net profit of Rs -107 crore as the comparison base for year-on-year estimates. It also references the most recent reported quarter (Q4 FY26) as another anchor point, with revenue of Rs 1,049 crore and net profit of Rs -31 crore. These figures are presented as the basis for the ranges published for Q1 FY27.

Longer-term profit and loss snapshot (annual)

The supplied profit and loss table provides annual figures (12 months) across Mar’22 to Mar’26. It shows operating profit of Rs 1,096.82 crore in Mar’26 versus Rs 1,318.42 crore in Mar’25. EBITDA is shown at Rs 1,460.49 crore in Mar’26 versus Rs 1,486.35 crore in Mar’25. EBIT is Rs 1,312.68 crore in Mar’26 versus Rs 1,375.12 crore in Mar’25, while interest cost is higher at Rs 1,766.85 crore in Mar’26 versus Rs 1,563.60 crore in Mar’25. The reported PAT remains negative across the period shown.

Market impact: what investors can and cannot infer

The board meeting intimation itself does not change the company’s financial position, but it provides a firm date for the Q1 FY27 approval process. The trading-window closure is a compliance indicator that the company is in the sensitive period ahead of results. The market snapshot in the supplied material puts the stock at around Rs 24, with the 12-month target range cited at Rs 21 to Rs 24, which suggests limited upside implied by that estimate band. The preview also highlights that the P/E is “not meaningful,” which typically reflects negative earnings, consistent with the reported PAT figures shown for recent years.

Analysis: why the August 12 meeting matters

For a listed NBFC, results timing affects investor attention, liquidity, and near-term positioning, particularly during the July-August reporting season. The preview’s estimated revenue range (Rs 865 to Rs 995 crore) is below the Q1 FY26 actual of Rs 1,041 crore, and the PAT estimate remains negative, though the stated year-on-year change shows a narrower loss versus Q1 FY26. Separately, the annual profit and loss snapshot shows that interest expense has been a large line item relative to operating metrics in Mar’26. Investors tracking the stock around the results date will likely focus on the unaudited standalone and consolidated numbers released after the board meeting, because the current filing does not provide them.

Company and contact details referenced

The material also lists the company’s registered office as Level 9, Centrum House, CST Road, Vidyanagari Marg, Kalina, Santacruz (East), Mumbai, Maharashtra 400098. The telephone number cited is 022-42159000, fax 022-42159940, and email info@centrum.co.in. The website referenced is http://www.centrum.co.in, and the notice says the board meeting document will be made available on the company website and on BSE and NSE.

Conclusion

Centrum Capital’s August 12, 2026 board meeting sets the formal timeline for approving Q1 FY27 unaudited results for the quarter ended June 30, 2026, while the trading window remains closed through August 14. The next concrete update is expected after the board considers and approves the standalone and consolidated results on the scheduled date.